Sotera Health Co. (SHC)
19.69
+0.18
(+0.92%)
USD |
NASDAQ |
Aug 26, 10:57
Sotera Health Price to Book Value : 8.441 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 8.364 |
| August 24, 2026 | 8.218 |
| August 21, 2026 | 8.390 |
| August 20, 2026 | 8.240 |
| August 19, 2026 | 8.145 |
| August 18, 2026 | 7.935 |
| August 17, 2026 | 8.060 |
| August 14, 2026 | 8.098 |
| August 13, 2026 | 8.154 |
| August 12, 2026 | 8.098 |
| August 11, 2026 | 8.192 |
| August 10, 2026 | 8.132 |
| August 07, 2026 | 8.085 |
| August 06, 2026 | 8.107 |
| August 05, 2026 | 7.708 |
| August 04, 2026 | 7.764 |
| August 03, 2026 | 7.712 |
| July 31, 2026 | 7.657 |
| July 30, 2026 | 7.652 |
| July 29, 2026 | 7.515 |
| July 28, 2026 | 7.614 |
| July 27, 2026 | 7.391 |
| July 24, 2026 | 7.438 |
| July 23, 2026 | 7.498 |
| July 22, 2026 | 7.412 |
| Date | Value |
|---|---|
| July 21, 2026 | 7.459 |
| July 20, 2026 | 7.468 |
| July 17, 2026 | 7.609 |
| July 16, 2026 | 7.832 |
| July 15, 2026 | 7.781 |
| July 14, 2026 | 7.618 |
| July 13, 2026 | 7.790 |
| July 10, 2026 | 7.897 |
| July 09, 2026 | 7.884 |
| July 08, 2026 | 7.489 |
| July 07, 2026 | 7.725 |
| July 06, 2026 | 7.657 |
| July 02, 2026 | 7.687 |
| July 01, 2026 | 7.609 |
| June 30, 2026 | 7.609 |
| June 29, 2026 | 8.026 |
| June 26, 2026 | 7.961 |
| June 25, 2026 | 7.833 |
| June 24, 2026 | 7.645 |
| June 23, 2026 | 7.256 |
| June 22, 2026 | 7.210 |
| June 18, 2026 | 7.247 |
| June 17, 2026 | 7.082 |
| June 16, 2026 | 7.348 |
| June 15, 2026 | 7.435 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ginkgo Bioworks Holdings, Inc. | 1.062 |
| Natera, Inc. | 26.84 |
| Myriad Genetics, Inc. | 0.9831 |
| Guardant Health, Inc. | -- |
| Quest Diagnostics, Inc. | 3.584 |
Price to Book Value Related Metrics
| PE Ratio | 34.63 |
| PS Ratio | 4.655 |
| PEG Ratio | 0.0597 |
| Price to Free Cash Flow | 51.57 |
| Price | 19.69 |
| Earnings Yield | 2.89% |
| Market Cap | 5.619B |
| PEGY Ratio | 0.0597 |
| Operating PE Ratio | 12.62 |
| Normalized PE Ratio | 28.10 |